Robert Dobrovolný

1.1k total citations
17 papers, 753 citations indexed

About

Robert Dobrovolný is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Robert Dobrovolný has authored 17 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 9 papers in Epidemiology and 5 papers in Organic Chemistry. Recurrent topics in Robert Dobrovolný's work include Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (9 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Robert Dobrovolný is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (9 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Robert Dobrovolný collaborates with scholars based in Czechia, United States and France. Robert Dobrovolný's co-authors include Robert J. Desnick, J. Ledvinová, Jan Bultas, Ai-Chu Huang, Shu-Chuan Chiang, Ni‐Chung Lee, Wuh‐Liang Hwu, Martin Hřebı́ček, Li‐Wen Hsu and Yin‐Hsiu Chien and has published in prestigious journals such as Stroke, Journal of Lipid Research and American Journal of Ophthalmology.

In The Last Decade

Robert Dobrovolný

17 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Dobrovolný Czechia 13 640 302 208 190 180 17 753
Daniel Oder Germany 12 748 1.2× 351 1.2× 246 1.2× 232 1.2× 179 1.0× 26 828
Josanne Cox‐Brinkman Netherlands 9 886 1.4× 375 1.2× 285 1.4× 242 1.3× 200 1.1× 11 991
Margaret Timmons United States 8 603 0.9× 267 0.9× 220 1.1× 196 1.0× 180 1.0× 10 761
Takahiro Tsukimura Japan 18 769 1.2× 380 1.3× 222 1.1× 310 1.6× 161 0.9× 47 868
Helena Poupětová Czechia 17 932 1.5× 407 1.3× 272 1.3× 196 1.0× 207 1.1× 40 1.1k
Clare Beesley United Kingdom 17 607 0.9× 262 0.9× 123 0.6× 240 1.3× 241 1.3× 29 980
E. Young United Kingdom 15 664 1.0× 281 0.9× 179 0.9× 138 0.7× 148 0.8× 23 768
Ai-Chu Huang Taiwan 11 608 0.9× 195 0.6× 93 0.4× 179 0.9× 337 1.9× 15 940
Shu-Chuan Chiang Taiwan 10 426 0.7× 179 0.6× 102 0.5× 135 0.7× 197 1.1× 20 721
María Josep Coll Spain 19 703 1.1× 228 0.8× 153 0.7× 218 1.1× 180 1.0× 37 1.1k

Countries citing papers authored by Robert Dobrovolný

Since Specialization
Citations

This map shows the geographic impact of Robert Dobrovolný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dobrovolný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dobrovolný more than expected).

Fields of papers citing papers by Robert Dobrovolný

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dobrovolný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dobrovolný. The network helps show where Robert Dobrovolný may publish in the future.

Co-authorship network of co-authors of Robert Dobrovolný

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Dobrovolný. A scholar is included among the top collaborators of Robert Dobrovolný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Dobrovolný. Robert Dobrovolný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brejchová, Kristýna, Ľubica Ďuďáková, Pavlína Skalická, et al.. (2019). IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact ofSLC4A11Variants on Pre-mRNA Splicing. Investigative Ophthalmology & Visual Science. 60(8). 3084–3084. 11 indexed citations
2.
Kuchař, Ladislav, Helena Hůlková, Befekadu Asfaw, et al.. (2018). Specific storage of glycoconjugates with terminal α-galactosyl moieties in the exocrine pancreas of Fabry disease patients with blood group B. Glycobiology. 28(6). 382–391. 6 indexed citations
3.
Ledvinová, J., et al.. (2017). Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II. Journal of Inherited Metabolic Disease. 41(2). 221–229. 17 indexed citations
4.
Dobrovolný, Robert, Martin Hřebı́ček, J. Ledvinová, et al.. (2016). X-Chromosome Inactivation Analysis in Different Cell Types and Induced Pluripotent Stem Cells Elucidates the Disease Mechanism in a Rare Case of Mucopolysaccharidosis Type II in a Female. Folia Biologica. 62(2). 82–89. 21 indexed citations
5.
Kuchař, Ladislav, Lukáš Krásný, Robert Dobrovolný, et al.. (2014). Fabry disease: renal sphingolipid distribution in the α-Gal A knockout mouse model by mass spectrometric and immunohistochemical imaging. Analytical and Bioanalytical Chemistry. 407(8). 2283–2291. 17 indexed citations
6.
Dobrovolný, Robert, Irina Nazarenko, Jung‐Min Kim, Dana Doheny, & Robert J. Desnick. (2011). Detection of large gene rearrangements in X-linked genes by dosage analysis: identification of novel α-galactosidase A (GLA) deletions causing Fabry disease. Human Mutation. 32(6). 688–695. 12 indexed citations
7.
Feldt‐Rasmussen, Ulla, Robert Dobrovolný, Irina Nazarenko, et al.. (2011). Diagnostic dilemma: A young woman with Fabry disease symptoms, no family history, and a “sequencing cryptic” α-galactosidase a large deletion. Molecular Genetics and Metabolism. 104(3). 314–318. 10 indexed citations
8.
Hwu, Wuh‐Liang, Yin‐Hsiu Chien, Ni‐Chung Lee, et al.. (2009). Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A). Human Mutation. 30(10). 1397–1405. 263 indexed citations
9.
Wozniak, Marcella A., Steven J. Kittner, Stanley Tuhrim, et al.. (2009). Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic Stroke. Stroke. 41(1). 78–81. 80 indexed citations
10.
Hůlková, Helena, Robert Dobrovolný, Befekadu Asfaw, et al.. (2008). Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 452(6). 651–665. 27 indexed citations
11.
Magage, Sudheera, Jean-Claude Lubanda, Jan Bultas, et al.. (2007). Natural history of the respiratory involvement in Anderson–Fabry disease. Journal of Inherited Metabolic Disease. 30(5). 790–799. 39 indexed citations
12.
Merta, M, Jana Reiterová, J. Ledvinová, et al.. (2006). A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population. Nephrology Dialysis Transplantation. 22(1). 179–186. 58 indexed citations
13.
Dobrovolný, Robert, Petra Lišková, J. Ledvinová, et al.. (2006). Mucolipidosis IV: Report of a Case with Ocular Restricted Phenotype Caused by Leaky Splice Mutation. American Journal of Ophthalmology. 143(4). 663–671.e2. 15 indexed citations
14.
Dobrovolný, Robert, Lenka Dvořáková, J. Ledvinová, et al.. (2005). Recurrence of Fabry disease as a result of paternal germline mosaicism for α-galactosidase a gene mutation. American Journal of Medical Genetics Part A. 134A(1). 84–87. 14 indexed citations
15.
Sikora, Jakub, Robert Dobrovolný, Helena Poupětová, et al.. (2005). Characterization of gana-1, a Caenorhabditis elegans gene encoding a single ortholog of vertebrate alpha-galactosidase and alpha-N-acetylgalactosaminidase.. BMC Cell Biology. 6(1). 5–5. 9 indexed citations
16.
Dobrovolný, Robert, Lenka Dvořáková, J. Ledvinová, et al.. (2005). Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population. Journal of Molecular Medicine. 83(8). 647–654. 130 indexed citations
17.
Asfaw, Befekadu, J. Ledvinová, Robert Dobrovolný, et al.. (2002). Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases. Journal of Lipid Research. 43(7). 1096–1104. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Oder Breakdown of academic impact, for papers by Josanne Cox‐Brinkman Breakdown of academic impact, for papers by Margaret Timmons Breakdown of academic impact, for papers by Takahiro Tsukimura Breakdown of academic impact, for papers by Helena Poupětová Breakdown of academic impact, for papers by Clare Beesley Breakdown of academic impact, for papers by E. Young Breakdown of academic impact, for papers by Ai-Chu Huang Breakdown of academic impact, for papers by Shu-Chuan Chiang Breakdown of academic impact, for papers by María Josep Coll
Rankless by CCL
2026